The National Cancer Institute's Office of Cancer Genomics (OCG) aims to advance the understanding of cancer at the molecular level with the ultimate goal of improving clinical outcomes. Through its various innovative and collaborative research programs, OCG fosters cancer genomics research (the systematic analysis of changes in the genomes of tumors) and the rapid translation of the resulting molecular insights into the clinic. Read more about OCG
Publications and data generated from OCG programs, as well as, other cancer-genomics-related resources are made publicly available on this website.
Sign up to receive updates from OCG, including the e-Newsletter.
RFA Pre-application Meeting Materials Available
Click here for materials from the RFA-CA-12-006 pre-application teleconference, including meeting presentations, an audio recording, and a list of frequently asked questions.
Funding Opportunity
The National Cancer Institute (NCI) has issued RFA-CA-12-006 for the Cancer Target Discovery and Development (CTDČ) Network.
Striking a Balance Between Feasible and Realistic Biological Models
CTD²
October 5, 2011
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
CGCI
July 27, 2011
Key pathways are frequently mutated in high risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
TARGET
June 16, 2011
Towards systematic functional characterization of cancer genomes
CTD²
July 13, 2011
Making sense of cancer genomic data
CTD²
April 8, 2011
